Mirum Pharmaceuticals Inc (MIRM)

Mar 28, 2025

Mirum Pharmaceuticals (MIRM) Down 1.9% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 28, 2025

Mar 27, 2025

Mirum Pharmaceuticals Says Livmarli Approved in Japan for Pruritus - Marketscreener.com

Mar 27, 2025

Mar 27, 2025

LIVMARLI Now Approved In Japan For ALGS And PFIC - Marketscreener.com

Mar 27, 2025

Mar 27, 2025

LIVMARLI Now Approved in Japan for ALGS and PFIC - Yahoo Finance

Mar 27, 2025

Mar 24, 2025

Mirum Pharmaceuticals: Set Fair For Share Price MomentumReversing My Sell Call (MIRM) - Seeking Alpha

Mar 24, 2025

Mar 24, 2025

Maintaining An 'Accumulate' Rating On Mirum Pharmaceuticals, Lots To Like (NASDAQ:MIRM) - Seeking Alpha

Mar 24, 2025

Mar 24, 2025

Exploring 3 High Growth Tech Stocks in the US Market - Simply Wall St

Mar 24, 2025

Mar 22, 2025

(MIRM) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Mar 22, 2025

Mar 21, 2025

Mirum's Heavy Dependence on Livmarli for Revenues Remains a Woe - Nasdaq

Mar 21, 2025

Mar 21, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Looks Inexpensive But Perhaps Not Attractive Enough - Simply Wall St

Mar 21, 2025

Mar 20, 2025

Mirum Pharmaceuticals SVP Jolanda Howe sells $107,342 in stock By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

Mirum’s Rare Disease Strategy: A Blueprint For Sustainable Growth - News & Insights

Mar 20, 2025

Mar 19, 2025

Mirum Pharmaceuticals SVP Jolanda Howe sells $107,342 in stock - Investing.com

Mar 19, 2025

Mar 18, 2025

Mirum Pharmaceuticals CEO sells $1.2 million in stock By Investing.com - Investing.com South Africa

Mar 18, 2025

Mar 18, 2025

Mirum Pharmaceuticals president sells $348k in stock - Investing.com India

Mar 18, 2025

Mar 18, 2025

Mirum Pharmaceuticals CEO sells $1.2 million in stock - Investing.com

Mar 18, 2025

Mar 18, 2025

Mirum Pharmaceuticals’ SVP Jolanda Howe sells $2.4 million in stock By Investing.com - Investing.com UK

Mar 18, 2025

Mar 18, 2025

Mirum Pharmaceuticals director Heron buys $24,214 in stock By Investing.com - Investing.com Australia

Mar 18, 2025

Mar 18, 2025

Mirum Pharmaceuticals director Heron buys $24,214 in stock - Investing.com India

Mar 18, 2025

Mar 17, 2025

Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for the Treatment of PFIC in Patients Three Months of Age and Older - Business Wire

Mar 17, 2025

Mar 13, 2025

Mirum Pharmaceuticals’ SWOT analysis: FDA nod boosts rare disease stock - Investing.com India

Mar 13, 2025

Mar 13, 2025

Mirum Pharmaceuticals director Heron buys $99,517 in stock - Investing.com India

Mar 13, 2025

Mar 13, 2025

Mirum Pharmaceuticals director Heron buys $99,517 in stock By Investing.com - Investing.com Australia

Mar 13, 2025

Mar 13, 2025

Mirum Pharmaceuticals’ SWOT analysis: FDA nod boosts rare disease stock By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 12, 2025

Mirum Pharmaceuticals at Leerink Conference: Growth in Rare Diseases By Investing.com - Investing.com Canada

Mar 12, 2025

Mar 11, 2025

(MIRM) Proactive Strategies - Stock Traders Daily

Mar 11, 2025

Mar 10, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - WICZ

Mar 10, 2025

Mar 10, 2025

Mirum Pharmaceuticals Strengthens Growth Strategy with Strategic New Hires and Equity Incentives - StockTitan

Mar 10, 2025

Mar 10, 2025

Mirum Pharmaceuticals director Heron buys $83,661 in stock By Investing.com - Investing.com South Africa

Mar 10, 2025

Mar 10, 2025

Mirum Pharmaceuticals director Heron buys $83,661 in stock - Investing.com India

Mar 10, 2025

Mar 10, 2025

MIRMMirum Pharmaceuticals Latest Stock News & Market Updates - StockTitan

Mar 10, 2025

Mar 06, 2025

Director’s Bold Move: Major Stock Purchase in Mirum Pharmaceuticals! - TipRanks

Mar 06, 2025

Mar 05, 2025

Mirum Pharmaceuticals’ president sells $676,928 in stock - Investing.com India

Mar 05, 2025

Mar 05, 2025

Mirum Pharmaceuticals’ president sells $676,928 in stock By Investing.com - Investing.com UK

Mar 05, 2025

Mar 04, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Bought by Rhumbline Advisers - Defense World

Mar 04, 2025

Mar 03, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $72.00 - Defense World

Mar 03, 2025

Mar 01, 2025

Wall Street Analysts Predict a 26.18% Upside in Mirum Pharmaceuticals (MIRM): Here's What You Should Know - MSN

Mar 01, 2025

Mar 01, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $72.00 at HC Wainwright - MarketBeat

Mar 01, 2025

Mar 01, 2025

Analyst Estimates: Here's What Brokers Think Of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) After Its Full-Year Report - Yahoo Finance UK

Mar 01, 2025

Mar 01, 2025

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 01, 2025

Feb 28, 2025

(MIRM) Technical Data - Stock Traders Daily

Feb 28, 2025

Feb 28, 2025

Mirum Pharmaceuticals: Strong Buy Rating Driven by Promising Financial Growth and Clinical Advancements - TipRanks

Feb 28, 2025

Feb 28, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Trading Down 8.2% After Earnings Miss - MarketBeat

Feb 28, 2025

Feb 28, 2025

Robert W. Baird Issues Positive Forecast for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price - MarketBeat

Feb 28, 2025

Feb 28, 2025

H.C. Wainwright lifts Mirum stock target to $72, maintains Buy By Investing.com - Investing.com UK

Feb 28, 2025

Feb 28, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025